TRACON PHARMACEUTICALS INC's ticker is TCON and the CUSIP is 89237H100. A total of 25 filers reported holding TRACON PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $576,000 | -29.9% | 1,287,873 | +6.5% | 0.00% | -100.0% |
| Q2 2019 | $822,000 | -41.7% | 1,209,203 | +17.5% | 0.00% | 0.0% |
| Q1 2019 | $1,410,000 | +166.0% | 1,029,485 | +22.4% | 0.00% | 0.0% |
| Q4 2018 | $530,000 | -68.0% | 840,900 | +4.1% | 0.00% | -50.0% |
| Q3 2018 | $1,657,000 | -46.9% | 808,100 | -34.4% | 0.00% | 0.0% |
| Q2 2018 | $3,121,000 | +165.2% | 1,231,500 | +140.7% | 0.00% | +100.0% |
| Q1 2018 | $1,177,000 | +32.7% | 511,600 | +93.3% | 0.00% | 0.0% |
| Q4 2017 | $887,000 | +84.0% | 264,700 | +73.0% | 0.00% | 0.0% |
| Q3 2017 | $482,000 | +81.9% | 153,000 | +38.3% | 0.00% | – |
| Q2 2017 | $265,000 | +11.8% | 110,600 | +75.0% | 0.00% | – |
| Q1 2017 | $237,000 | +20.3% | 63,200 | +56.8% | 0.00% | – |
| Q4 2016 | $197,000 | +107.4% | 40,300 | +181.8% | 0.00% | – |
| Q3 2016 | $95,000 | – | 14,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|